NIH-funded research Sbir 1 grant

Using wearable technology to help cancer survivors quit smoking

Official title: ASHES: Assessing Smoking BeHavior with ThErmal Sensing to Prevent Relapse

Funded at Sensewhy, INC. · NIH-11069872 · Data updated 2026-11-12

This study is looking at how a special device can help cancer survivors keep track of their smoking habits and avoid going back to smoking, by providing real-time support and understanding what triggers their cravings.

Quick facts

Grant typeSbir 1 grant
Study typeNIH-funded research
Funding institutionSensewhy, INC.
NIH-funded
Lab location1 site (Chicago, United States)
Project startApril 15, 2025
Project endMarch 31, 2026
Funding year2025
Award (this year)$399,891
NIH project number1R43CA298750-01
Project IDNIH-11069872 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are cancer survivors who currently smoke and are seeking support to quit.

Less likely to help

Patients who have never smoked or those who are not cancer survivors may not benefit from this research.

What this research studies

This research investigates how wearable technology can monitor smoking behavior in cancer survivors to help prevent relapse. By using a device called SmokeMon, which unobtrusively tracks smoking habits, the study aims to gather real-time data on smoking triggers and motivations. Participants will also use a smartphone app to report their experiences, allowing researchers to provide timely support and interventions. The goal is to improve smoking cessation outcomes for cancer survivors who are at high risk of relapse.

Why it matters

Potential benefit: If successful, this research could significantly enhance smoking cessation efforts for cancer survivors, reducing their risk of cancer recurrence and improving overall health outcomes.

How similar studies have gone: Previous research has shown promise in using technology for smoking cessation, but this specific approach integrating wearable devices and real-time feedback is relatively novel.

Where this research is happening

  • Sensewhy, INC.
    Chicago, United States
    Active

Researchers

  • Principal investigator: Pedram, Mahdi — Sensewhy, INC.
  • Study coordinator: Pedram, Mahdi

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.